Centers for Disease Control and Prevention (US), National Center for Infectious Diseases, Viral Hepatitis Surveillance. Disease burden from hepatitis A, B, and C in the United States. 2005 [cited 2006 Nov 24]. Available from: URL: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/dz_burden.htm
2.
ArmstrongGLWasleyASimardEPMcQuillanGMKuhnertWLAlterMJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med2006; 144:705–14.
3.
EdlinBR. Five million Americans infected with the hepatitis C virus: a corrected estimate (abstract #44). 56th Annual Meeting of the American Association for the Study of Liver Diseases; 2005 Nov 11-15; Boston, Massachusetts. In: Hepatology2005; 42(4 Suppl 1):213A.
4.
GlynnMRhodesP. Estimated HIV prevalence in the United States at the end of 2003 Abstract no. T1-B1101. Proceedings of the National HIV Prevention Conference; 2005 Jun 12-15; Atlanta, Georgia. Abstract 595. Also available from: URL: http://www.aegis.com/conferences/NHIVPC/2005/T1-B1101.pdf [cited 2006 Nov 24].
5.
GoldsteinSTAlterMJWilliamsITMoyerLAJudsonFNMottramK. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis2002; 185:713–9.
CDC (US). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), part II: immunization of adults. MMWR Recomm Rep2006;55(RR-16):1–25. Also available from: URL: http://www.cdc.gov/mmwr/PDF/rr/rr5516.pdf [cited 2007 Jan 8].
8.
CDC (US). Estimated numbers of cases of HIV/AIDS, by year of diagnosis and selected characteristics, 2001–2005–33 states and U.S. dependent areas with confidential name-based HIV infection reporting. HIV/AIDS surveillance report, 2005 Vol. 17. Atlanta: Department of Health and Human Services, CDC; 2006 Also available from: URL: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2005report/table1.htm [cited 2007 Jan 15].
9.
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep1998;47(RR-19):1–39. Also available from: URL: http://www.cdc.gov/mmwr/PDF/rr/rr4719.pdf [cited 2006 Nov 24].
10.
Des JarlaisDCDiazTPerlisTVlahovDMaslowCLatkaM. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol2003; 157:467–71.
11.
Des JarlaisDCFisherDGNewmanJCTrubatchBNYancovitzMPaoneD. Providing hepatitis B vaccination to injection drug users: referral to health clinics vs. on-site vaccination at a syringe exchange program. Am J Public Health2001; 91:1791–2.
12.
HahnJAPage-ShaferKLumPJBourgoisPSteinEEvansJL. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis2002; 186:1558–64.
13.
WasleyAAlterMJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis2000; 20:1–16.
14.
BuffingtonJMurrayPJSchlangerKShihLBadsgardTHennessyRR. Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs. Public Health Rep2007; 122(Suppl 2):63–7.
15.
GunnRAMurrayPJAckersMLHardisonWGMargolisHS. Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis2001; 28:166–70.
16.
MarkKEMurrayPJCallahanDBGunnRA. Medical care and alcohol use after testing hepatitis C antibody positive at STD clinic and HIV test site screening programs. Public Health Rep2007; 122:37–43.
17.
MacKellarDAValleroyLASecuraGMMcFarlandWShehanDFordW. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health2001; 91:965–71.
FriedenTRDas-DouglasMKellermanSEHenningKJ. Applying public health principles to the HIV epidemic. N Engl J Med2005; 353:2397–402.
20.
National Coalition of State and Territorial AIDS Directors and National Coalition of STD Directors. STD/HIV Prevention integration; 2002 [cited 2006 Dec 8]. Available from: URL: http://www.ncsddc.org/docs/STDHIVIssuePaperFinal.pdf
HoffmanHLCastro-DonlanCAJohnsonVMChurchDR. The Massachusetts HIV, hepatitis, addiction services integration (HHASI) experience: responding to the comprehensive needs of individuals with co-occurring risks and conditions. Public Health Rep2004; 119:25–31. Also available from: URL: http://www.publichealthreports.org/userfiles/119_1/119025.pdf [cited 2006 Nov 24].
23.
StraussSMAstoneJMDes JarlaisDCHaganH. Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units. AIDS Patient Care STDS2005; 19:78–88.
24.
WardJWFentonKA. CDC and progress toward integration of HIV, STD, and viral hepatitis prevention. Public Health Rep2007; 122(Suppl 2):99–101.
CDC (US). Hepatitis B vaccination among high-risk adolescents and adults—San Diego, California, 1998 −2001. MMWR Morb Mortal Wkly Rep 2002;19;51(28):618–21. Also available from: URL: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5128a3.htm [cited 2006 Nov 24].
RodewaldLETanLJ. Balancing the childhood immunization program with the urgent needs for adult hepatitis B immunization. Public Health Rep2007; 122(Suppl 2):52–4.
30.
HarrisJLJonesTSBuffingtonJ. Hepatitis B vaccination in six STD clinics in the United States committed to integrating viral hepatitis prevention services. Public Health Rep2007; 122(Suppl 2):42–7.
31.
ZimmermanRFinleyCRabinsCMcMahonK. Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005. Public Health Rep2007; 122(Suppl 2):18–23.
32.
SubiadurJHarrisJLRietmeijerCA. Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado. Public Health Rep2007; 122(Suppl 2):12–7.
33.
HerlihyEJKleinSJNewcombMLBlogDSBirkheadGS. Expansion of adult hepatitis A and B vaccination in STD clinics and other settings in New York State. Public Health Rep2007; 122(Suppl 2):36–41.
34.
BaldyLMUrbasCHarrisJLJonesTSReichertPE. Establishing a viral hepatitis prevention and control program: Florida's experience. Public Health Rep2007; 122(Suppl 2):24–30.
35.
HeseltineGMcFarlaneJ. Texas statewide hepatitis C counseling and testing, 2000-2005. Public Health Rep2007; 122(Suppl 2):6–11.
36.
KleinSJWrightLNBirkheadGSMojicaBAKlopfLCKleinLA. Promoting HCV treatment completion for prison inmates: New York State's Hepatitis C Continuity Program. Public Health Rep2007; 122(Suppl 2):83–8.
37.
McLaughlinP. Viral hepatitis vaccination in an opioid treatment program: Hartford, Connecticut, 2002-2005. Public Health Rep2007; 122(Suppl 2):48–51.
38.
StopkaTJMarshallCBluthenthalRNWebbDSTruaxSR. HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates. Public Health Rep2007; 122(Suppl 2):68–73.
39.
HennessyRRWeisfuseIBSchlangerK. Does integrating viral hepatitis services into a public STD clinic attract injection drug users for care?Public Health Rep2007; 122(Suppl 2):31–5.
40.
HoneycuttAAHarrisJLKhavjouOBuffingtonJJonesTSReinDB. The costs and impacts of testing for hepatitis C virus antibody in public STD clinics. Public Health Rep2007; 122(Suppl 2):55–62.
41.
WhiticarPLibertiT. Advancing integration of HIV, STD, and viral hepatitis services: state perspectives. Public Health Rep2007; 122(Suppl 2):91–5.
42.
ZevinB. Managing chronic hepatitis C in primary-care settings: more than antiviral therapy. Public Health Rep2007; 122(Suppl 2):78–82.
43.
AroraSThorntonKJenkuskySMParishBScalettiJV. Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico. Public Health Rep2007; 122(Suppl 2):74–7.
44.
KresinaTFHoffmanKLubranRClarkHW. Integrating hepatitis services into substance abuse treatment programs: new initiatives from SAMHSA. Public Health Rep2007; 122(Suppl 2):96–8.
ArmstrongGL. Commentary: modeling the epidemiology of hepatitis C and its complications. Int J Epidemiol2003; 32:725–6.
47.
PerzJFAlterMJ. The coming wave of HCV-related liver disease: dilemmas and challenges. J Hepatol2006; 44:441–3.
48.
WasleyAFinelliLBellBPAlterMJ. The knowledge and behavior of HCV-infected persons identified in a national seroprevalence survey, United States, 2001–2004. Abstract [Poster 445]. Proceedings of the 12th International Symposium on Viral Hepatitis and Liver Disease; 2006 Jul 1-5; Paris, France.
49.
Health Resources and Services Administration (US). HIV/AIDS Bureau. Education and training: AIDS education and training centers [cited 2006 Oct 20]. Available from: URL: http://hab.hrsa.gov/educating.htm
50.
Health Resources and Services Administration (US). Ryan White CARE Act [cited 2006 Oct 20]. Available from: URL: http://hab.hrsa.gov/history.htm